SAN DIEGO--(BUSINESS WIRE)--March 31, 2006--dj Orthopedics, Inc. (NYSE: DJO), a global medical device company specializing in rehabilitation and regeneration products for the non-operative orthopedic and spine markets, today announced that the Federal Trade Commission (FTC) has completed its antitrust review of dj Orthopedics' planned acquisition of Aircast
Incorporated and will permit the transaction to go forward. On February 27, 2006, dj Orthopedics announced that it had signed a definitive agreement to purchase Aircast Incorporated from its stockholders, including majority owner Tailwind Capital, for approximately $290 million in cash. With the FTC review complete, the Company said it expects the transaction to close in the
near future, subject to certain other customary closing conditions.
About Aircast
Aircast is a leading designer and manufacturer of orthopedic devices, including ankle bracing products, and vascular systems. The company has a 30-year track record of consistent revenue growth and cash flow generation, built from its focused portfolio of products with proven clinical benefits and long-standing relationships with key opinion leaders. In addition to ankle braces, Aircast's orthopedic product line includes a broad array of cold therapy systems, fracture boots and specialty products. The vascular systems business includes products to prevent deep vein thrombosis (DVT), which can occur after surgery.
About dj Orthopedics
dj Orthopedics is a global medical device company specializing in rehabilitation and regeneration products for the non-operative orthopedic and spine markets. Marketed under the DonJoy and ProCare brands, the Company's broad range of over 600 rehabilitation products, including rigid knee braces, soft goods and pain management products, are used in the prevention of injury, in the treatment of chronic conditions and for recovery after surgery or injury. The Company's regeneration products consist of bone growth stimulation devices that are used to treat nonunion fractures and as an adjunct therapy after spinal fusion surgery. Together, these products provide solutions throughout the patient's continuum of care. The Company sells its products in the United States and in more than 50 other countries through networks of agents, distributors and its direct sales force. Customers include orthopedic, podiatric and spine surgeons, orthotic and prosthetic centers, third-party distributors, hospitals, surgery centers, physical therapists, athletic trainers and other healthcare professionals. For additional information on the Company, please visit www.djortho.com.
SOURCE: dj Orthopedics, Inc.
dj Orthopedics, Inc.
Mark Francois, 760-734-4766
